Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04665271 · ClinicalTrials.gov registry record · NA
Acceptability and Efficacy of Zemedy App Versus Education and Relaxation Training App for IBS
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 453
- Enrollment target
NCT04665271: Completed NA study, sponsored by University of Pennsylvania.
NCT04665271 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 453 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04665271, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 453 participants
- Enrollment target
Study Summary
The purpose of this research is to assess if a new digital app version of a self-help intervention for Irritable Bowel Syndrome (IBS), is an acceptable and effective treatment for improving the overall quality of life in patients with IBS.
Interventions
- BEHAVIORAL Zemedy App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 453 participants |
| Start Date | 2021-03-01 |
| Est. Completion | 2024-05-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04665271
The ClinicalTrials.gov registry entry for NCT04665271 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 453 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Zemedy App is the first listed.
NCT04665271 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04665271 about?
NCT04665271 is a clinical study titled "Acceptability and Efficacy of Zemedy App Versus Education and Relaxation Training App for IBS". The purpose of this research is to assess if a new digital app version of a self-help intervention for Irritable Bowel Syndrome (IBS), is an acceptable and effective treatment for improving the overall quality of life in patients with IBS.
What is the current status of trial NCT04665271?
This trial is currently completed. It is a NA study. The enrollment target is 453 participants. The study started on 2021-03-01. Estimated completion is 2024-05-28.
What interventions are being tested in trial NCT04665271?
The interventions under investigation include: Zemedy App (BEHAVIORAL).
Who is sponsoring clinical trial NCT04665271?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.